Skip to main content

All information is provided without guarantee.

see.ip is a service from the Austrian Patent Office.

info@patentamt.at

Impressum Datenschutz

Details for 2021835087

Up to date per 04.04.2026

Actions

Details for 2021835087

Title / Product Name

ORALE FORMULIERUNGEN VON TENAPANOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021835087

EP Publication Number

4255397

E-Number

1887306

Language

EN

PCT Number

US21062069

Publication Date

11.10.2023 A

18.02.2026 B1

Registration Date

18.02.2026

AT Publication Date

15.03.2026

Application Date

06.12.2021

Registration Number

-

Priorities

04.12.2020

US

202063199078 P

IPC

A61K 9/16 20060101AFI20220614BHEP

Maximum Duration of Protection

06.12.2041

Owner

Ardelyx, Inc.34175 Ardenwood Blvd. Fremont, California 94555US

AstraZeneca ABForskargatan 18 151 85 SödertäljeSE

Representative

No representatives present

Inventor

GUNNARSSON, Cecilia 431 50 MölndalSE

SWENSON, Magnus 151 85 SodertéljeSE

MATIC, Hanna 151 85 SodertéljeSE

SALOMONSSON, John 151 85 SodertéljeSE

KARLSSON, Eva 151 85 SodertéljeSE

Information about Fees